Search Result "Mammalian target of rapamycin (mTOR)"


mTOR: A Novel Therapeutic Target for Diseases of Multiple Systems

Journal: Current Drug Targets
Volume: 16 Issue: 10 Year: 2015 Page: 1107-1132
Author(s): Zhao Zhong Chong

Age-Related Neurodegeneration Prevention Through mTOR Inhibition: Potential Mechanisms and Remaining Questions

Journal: Current Topics in Medicinal Chemistry
Volume: 15 Issue: 21 Year: 2015 Page: 2139-2151
Author(s): Jordan B. Jahrling,Remi-Martin Laberge

Longevity Pathways (mTOR, SIRT, Insulin/IGF-1) as Key Modulatory Targets on Aging and Neurodegeneration

Journal: Current Topics in Medicinal Chemistry
Volume: 15 Issue: 21 Year: 2015 Page: 2116-2138
Author(s): Caio Henrique Mazucanti,Joao Victor Cabral-Costa,Andrea Rodrigues Vasconcelos,Diana Zukas Andreotti,Cristoforo Scavone,Elisa Mitiko Kawamoto

Mitochondrial Dysfunction and Its Relationship with mTOR Signaling and Oxidative Damage in Autism Spectrum Disorders

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 15 Issue: 5 Year: 2015 Page: 373-389
Author(s): Kunio Yui,Atsushi Sato,George Imataka

Combination Therapy of Intraperitoneal Rapamycin and Convection- Enhanced Delivery of Nanoliposomal CPT-11 in Rodent Orthotopic Brain Tumor Xenografts

Journal: Current Cancer Drug Targets
Volume: 15 Issue: 4 Year: 2015 Page: 352-362
Author(s): Marina Mendiburu-Elicabe,Jon Gil-Ranedo

A Novel Quinoline Based Second-generation mTOR Inhibitor that Induces Apoptosis and Disrupts PI3K-Akt-mTOR Signaling in Human Leukemia HL-60 Cells

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 15 Issue: 10 Year: 2015 Page: 1297-1304
Author(s): Suresh Kumar,Santosh Kumar Guru,Vunnam Venkateswarlu,Fayaz Malik,Ram A. Vishwakarma,Sanghapal D. Sawant,Shashi Bhushan

The PI3K-AKt-mTOR Pathway and New Tools to Prevent Acquired Hormone Resistance in Breast Cancer

Journal: Current Pharmaceutical Biotechnology
Volume: 16 Issue: 9 Year: 2015 Page: 804-815
Author(s): Andrea Nicolini,Paola Ferrari,Lucie Kotlarova,Giuseppe Rossi,Pier M. Biava

Anti-Angiogenic Drugs in the Treatment of Metastatic Renal Cell Carcinoma: Advances in Clinical Application

Journal: Current Vascular Pharmacology
Volume: 13 Issue: 3 Year: 2015 Page: 381-391
Author(s): Ole H. Nielsen,Daniela Grimm,Markus Wehland,Johann Bauer,Nils E. Magnusson

Programming Apoptosis and Autophagy with Novel Approaches for Diabetes Mellitus

Journal: Current Neurovascular Research
Volume: 12 Issue: 2 Year: 2015 Page: 173-188
Author(s): Kenneth Maiese

Evaluation of the in vivo Safety Profiles of Rictor Inhibition Using a Zebrafish Model

Journal: Current Pharmaceutical Design
Volume: 21 Issue: 12 Year: 2015 Page: 1645-1653
Author(s): Yang Cao,Lijun Jiang,Lei Zhao,Xiaoxi Zhou,Na Wang,Peilin Zhang,Yuting Tang,Jianfeng Zhou

Previous   Next

Go To   Results 1 - 1 of 76

Filter Result

Volume Year
Content Type
Ads
© 2024 Bentham Science Publishers | Privacy Policy